References
- Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Control Rel 2003;90:261–80
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm 1999;185:129–88
- Pérez C, Castellanos IJ, Costantino HR, et al. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J Pharm Pharmcol 2002;54:301–13
- Chen S, Pieper R, Webster DC, Singh J. Triblock copolymers: synthesis, characterization, and delivery of a model protein. Int J Pharm 2005;288:207–18
- Pisal DS, Kosloski MP, Baluiyer SV. Delivery of therapeutic proteins. J Pharm Sci 2010;99:2557–75
- Castellanos IJ, Cruz G, Crespo R, Griebenow K. Encapsulation-induced aggregation and loss in activity of γ-chymotrypsin and their prevention. J Control Rel 2002;81:307–19
- Hutchinson FG, Furr BJA. Biodegradable polymer systems for the sustained release of polypeptides. J Control Rel 1990;13:279–94
- Jalil R, Nixon JR. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsulation 1990;7:297–325
- Panyam J, Dali MM, Sahoo SK, et al. Polymer degradation and in vitro release of a model protein from (d,l-lactide-co-glycolide) nano-and microparticles. J Control Rel 2003;92:173–87
- Alonso MJ, Gupta RK, Min C, et al. Biodegradable microspheres as controlled-release tetanus toxid delivery systems. Vaccine 1994;12:299–306
- Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm 1998;45:285–94
- Shantha Kumar TR, Soppimath K, Nachaegari SK. Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotech 2006;7:261–76
- Kline BJ, Beckman EJ, Russell AJ. One-step biocatalytic synthesis of linear polyesters with pendant hydroxyl groups. J American Chem Soc 1998;120:9475–80
- Namekawa S, Uyama H, Kobayashi S. Enzymatic synthesis of polyesters from lactone, dicarboxylic acid divinyl esters, and glycols through combination of ring–openening polymerization and polycondensation. Biomacromolecules 2000;1:335–8
- Kallinteri P, Higgins S, Hutcheon G, et al. Novel functionalized biodegradable polymers for nanoparticle drug delivery systems. Biomacromolecules 2005;6:1885–94
- Puri S, Kallinteri P, Higgins S, et al. Drug incorporation and release of water soluble drugs from novel functionalized poly(glycerol adipate) nanoparticles. J Control Rel 2008;125:59–67
- Thompson CJ, Hansford D, Higgins S, et al. Evaluation of ibuprofen-loaded microspheres prepared from novel copolyesters. Int J Pharm 2007;329:53–61
- Tawfeek H, Khidr S, Samy E, et al. Poly(Glycerol Adipate-co-ω-Pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery. Pharm Res 2011;28:2086–97
- Gaskell EE, Hobbs G, Rostron C, Hutcheon GA. Encapsulation and release of alpha-chymotrypsin from poly(glycerol adipate-co-omega-pentadecalactone) microparticles. J Microencapsulation 2008;25:187–95
- O’Donnell PB, McGinity JW. Preparation of microspheres by solvent evaporation technique. Adv Drug Deliv Rev 1997;28:25–42
- Morales JO, Joks GM, Lamprecht A, et al. A design of experiments to optimize a new manufacturing process for high activity protein-containing submicron particles. Drug Dev Ind Pharm 2013; Epub ahead of print
- Thompson CJ, Hansford D, Higgins S, et al. Enzymatic synthesis and evaluation of new novel ω-pentadecalactone polymers for the production of biodegradable microspheres. J Microencapsulation 2006;23:213–26
- Pamujula S, Graves RA, Kishore V, Mandal TK. Preparation and in vitro characterization of amifostine biodegradable microcapsule. Eur J Pharm Biopharm 2004;57:213–18
- Rabbani NR, Seville PC. The influence of formulation components on the aerosolisation properties of spray dried-powders. J Control Rel 2005;110:130–40
- Srinivasan C, Katare YK, Muthukumaran T, Panda AK. Effect of additives on encapsulation efficiency, stability and bioactivity of entrapped lysozyme from biodegradable polymer particles. J Microencapsulation 2005;22:127–38
- Telkov MV, Deminal GR, Voloshin SA, et al. Proteins of the Rpf (Resuscitation Promoting Factor) family are peptidoglycan hydrolases. Biochemistry 2006;71:414–22
- Kline BJ, Beckman EJ, Russell AJ. One-step synthesis of linear polyesters with pendant hydroxyl groups. J Am Chem Soc 1998;120:9475–80
- Watts PJ, Davies MC, Melia CD. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit Rev Ther Drug Carr Sys 1990;7:235–59
- Tan H, Ye J. Surface morphology and in vitro release performance of double-walled PLLA/PLGA microspheres entrapping a highly water-soluble drug. Applied Surf Sci 2008;255:353–6
- Cai C, Mao S, Germershaus O, et al. Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA. J Microencapsulation 2009;l26:334–45
- Tuncay M, Cali S, Ka HS, et al. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro.in vivo evaluation. Int J Pharm 2000;195:179–88
- Youan BBC, Benoit MA, Baras B, Gillard J. Protein-loaded poly(ε-caprolactone) microparticles. I. Optimization of the preparation by (water-in-oil)-in water emulsion solvent evaporation. J Microencapsulation 1999;16:587–99
- Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Rel 2007;119:77–85
- Kim BK, Hwang SJ, Park JB, Park HJ. Characteristics of felodipine-located poly(ε-caprolactone) microspheres. J Microencapsulation 2005;22:193–203
- McGee PJ, Davis SS, O'Hagan DT. Zero order release of protein from poly(-lactide-co-glycolide) microparticles prepared using a modified phase separation technique. J Control Rel 1995;34:77–86
- Li Y, Pei Y, Zhang X, et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Rel 2001;71:203–11
- Jiang G, Woo BH, Kang F, et al. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(d,l-lactide-co-glycolide) microspheres. J Control Rel 2002;79:137–45
- Tsai T. Adsorption of peptides to poly(d,l-lactide-co-glycolide): 2. Effect of solution properties on the adsorption. Int J Pharm 1996;127:43–52
- Singh M, Briones M, Ott G, O′Hagan D. Cationic microparticles: a potent delivery system for DNA vaccine. Proc Natl Acad Sci USA 2000;97:811–16
- Bala I, Bhardwaj V, Hariharan S, et al. Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid. Nanotechnology 2005;16:2819–22
- Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475–90
- Edlund U, Abertsson AC. Degradable polymer microspheres for controlled drug release. Adv Polymer Sci 2002;157:67–112
- Luan X, Skupin M, Siepmann J, Bodmeier R. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles. Int J Pharm 2006;324:168–75
- Crotts G, Sah G, Park TG. Adsorption determines in vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation. J Control Rel 1997;47:101–11
- Viswanathan NB, Patil SS, Pandit JK, et al. Morphological changes in degrading PLGA and P(DL)LA microspheres: implications for the design of controlled release systems. J Microencapsulation 2001;18:783–800
- Ghaderi R, Carlfors J. Biological activity of lysozyme after entrapment in poly(d,l-lactide-co-glycolide)-microspheres. Pharm Res 1997;14:1556–64
- Davies RC, Neuberger A, Wilson BM. The dependence of lysozyme activity on pH and ionic strength. Biochim Biophys Acta 1969;178:294–305
- Chang KY, Carr CW. Studies on the structure and function of lysozyme. I. The effect of pH and cation concentration of lysozyme activity. Biochim Biophys Acta 1971;229:496–503
- Osawa T. Lysozyme substrates. Synthesis of p-nitrophenyl 2-acetamido-4-O-(2-acetamido-2-deoxy-β-(1→6)isomer. Carbohydr Res 1966;1:435–43
- Osawa T, Nakazawa Y. Lysozyme substrates. Chemical synthesis of p-nitrophenyl O-(2-acetamido-2-deoxy-β-Image-glucopyranosyl)-(1→4)-O-(2-acetamido-2-deoxy-β-Image-glucopyranosyl)-(1→4)-2-acetamido-2-deoxy-β-Image-glucopyranoside and its reaction with lysozyme. Biochim Biophys Acta 1966;130:56–63
- Ballardie FW, Capon B, Cuthbert MW, Dearie WM. Some studies on catalysis by lysozyme. Bioorg Chem 1977;6:483–509
- Van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactide-co-glycolic acid) microparticles. Pharm Res 2000;10:1159–67
- Pérez-Rodriguez C, Montano N, Gonzalez K, Griebnow K. Stabilization of α-chymotrypsin at the CH2CL2/water interface and upon water-in-oil-in-water encapsulation in PLGA microspheres. J Control Rel 2003;89:71–85
- Sah H. Protein behavior at the water/methylene chloride interface. J Pharm Sci 1999;88:1320–5
- Giteau A, Venier-Julienne MC, Marchel S, et al. Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm 2008;70:127–36